Summary
- Current Price
- As of today, TXG price is $93.50, up +5.34% on
- Current Price All-Time High
- TXG price is currently -55.26% below its historical high of $208.99 set on
- Market Cap
- TXG current market cap is $12B, up +682.06% over the past 365 days
- Revenue
- TXG current annual revenue is $642.82M, up +5.25% year-over-year
- Next Earnings
- The next earnings release for TXG is on
Profile
| Metric | Value |
|---|---|
| Full Name | 10x Genomics, Inc. |
| Ticker | NASDAQ: TXG |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | 10xgenomics.com |
| Employees | 1,306 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $93.50 | |
| Price, 1D Change | +5.34% | |
| $12B | ||
| - | ||
| - | ||
| 2.21 | ||
| $642.82M | ||
| Revenue, 1Y Change | +5.25% | |
| -$0.35 | ||
| EPS, 1Y Change | +76.98% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:2 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.35 | ||
| EPS Estimate | $0.04 | N/A |
| EPS Est. Change | +110.51% | N/A |
| $642.82M | ||
| Revenue Estimate | $620.18M | N/A |
| Revenue Est. Change | -3.52% | N/A |
| Current Price | $93.50 | |
| Price Target | $60.00 | - |
| Price Tgt. Change | -35.83% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.61 | -$1.52 | -147.22% | |
| -$0.03 | -$0.35 | -1,207.49% | |
| $0.04 | N/A | +110.51% | |
| $0.08 | N/A | +121.97% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $610.74M | $610.79M | +0.01% | |
| $640.23M | $642.82M | +0.41% | |
| $620.18M | N/A | -3.52% | |
| $680.93M | N/A | +5.93% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $93.50 | |
| $34.75 | ||
| $64.80 | ||
| $41.24 | ||
| $67.10 | ||
| $7.91 | ||
| 2.21 | ||
| $5.19 | ||
| 77.03 | ||
| 72.00% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $642.82M | ||
| -$0.35 | ||
| $443.88M | ||
| 69.05% | ||
| -$110.89M | ||
| -17.25% | ||
| -$43.54M | ||
| -6.77% | ||
| -$56.38M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.11 | ||
| 4.46 | ||
| 4.09 | ||
| - | ||
| 4 | ||
| 28.68 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 19.75 | ||
| 14.76 | ||
| -271.40 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $796.33M | ||
| $523.41M | ||
| $1.04B | ||
| $684.45M | ||
| $245.04M | ||
| $153.45M | ||
| $84.36M | ||
| $10.99M | ||
| $12.73M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $686.37M | ||
| $554.77M | ||
| $198.94M | ||
| $0.00 | ||
| $43.82M | ||
| $0.00 | ||
| $3.64M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $136.05M | ||
| -$13.44M | ||
| $6.80M | ||
| $5.94M | ||
| $130.12M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Leerink Partners | → | |
| Piper Sandler | → | |
| Argus Research | ||
| UBS | → | |
| RBC Capital | ||
| Stephens & Co. | → | |
| Piper Sandler | → | |
| Canaccord Genuity | → | |
| Morgan Stanley | → | |
| Citigroup | → |
Analyst sentiment
Institutional ownership
No data
Screeners with TXG
FAQ
- What is the ticker symbol for 10x Genomics, Inc.?
- The ticker symbol for 10x Genomics, Inc. is NASDAQ:TXG
- Does 10x Genomics, Inc. pay dividends?
- No, 10x Genomics, Inc. does not pay dividends
- What sector is 10x Genomics, Inc. in?
- 10x Genomics, Inc. is in the Healthcare sector
- What industry is 10x Genomics, Inc. in?
- 10x Genomics, Inc. is in the Medical Devices industry
- What country is 10x Genomics, Inc. based in?
- 10x Genomics, Inc. is headquartered in United States
- When did 10x Genomics, Inc. go public?
- 10x Genomics, Inc. initial public offering (IPO) was on September 12, 2019
- Is 10x Genomics, Inc. in the S&P 500?
- No, 10x Genomics, Inc. is not included in the S&P 500 index
- Is 10x Genomics, Inc. in the NASDAQ 100?
- No, 10x Genomics, Inc. is not included in the NASDAQ 100 index
- Is 10x Genomics, Inc. in the Dow Jones?
- No, 10x Genomics, Inc. is not included in the Dow Jones index
- When was 10x Genomics, Inc. last earnings report?
- 10x Genomics, Inc.'s most recent earnings report was on August 6, 2026
- When does 10x Genomics, Inc. report earnings?
- The next expected earnings date for 10x Genomics, Inc. is November 5, 2026
Data Sources & References
- TXG Official Website www.10xgenomics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1770787/000162828026007822/0001628280-26-007822-index.htm
- TXG Profile on Yahoo Finance finance.yahoo.com/quote/TXG
- TXG Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/txg